Painreform Ltd  (PRFX)

News about Painreform Ltd

Navigating Uncertainty: PainReform Ltd*s Path to Compliance and Resilience
May 31 2024
PainReform Ltd Announces Non-Compliance with Nasdaq Listing RequirementsPainReform Ltd, a clinical-stage specialty pharmaceutical company, recent...

PainReform CEO Ilan Hadar Discusses PRF-110*s Potential in Combating the Opioid Epidemic
May 08 2024
IntroductionIn a recent interview with Proactiveinvestors.com, PainReform Ltd.*s CEO, Ilan Hadar, shed light on the latest developments surr...

PainReform Successfully Closes Public Offering, Raises Significant Funds for Clinical Development
Apr 18 2024
TEL AVIV, Israel - PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of establi...

PainReform Secures $4 Million in Public Offering, Fueling Growth in Pharmaceutical Innovation
Apr 16 2024
PainReform*s Public Offering Signals Growth in Clinical-Stage Pharmaceutical IndustryIn a recent announcement, PainReform Ltd. (Nasdaq: PRFX), a ...

A New Era in Postoperative Pain Management: PainReform?s Non-Opiate Topical Solution PRF-110 Shows Unequivocal Superiority Over Market Leader
Apr 09 2024
In what is undoubtedly a significant breakthrough for PainReform Ltd, the non-opiate topical treatment of the Israel-based specialty pharmaceutical co...

Revolutionary Pain Management Breakthrough: PainReform*s PRF-110 Enrolls 50% in Phase 3 Clinical Trial, Top-Line Results Expected by mid-2024
Apr 02 2024
In the realm of modern medicine, the ever-elusive quest for effective pain management techniques has long been a topic of intense research and develop...

PRF-110: Redefining Postoperative Pain Relief with Pioneering Formulation and Extended Relief
Jan 03 2024
In a groundbreaking development in the field of postoperative pain management, PainReform has recently unveiled the astounding results of their head-t...

PainReform Secures $1.3 Million in Funding through Warrant Exercise, Accelerating Innovation in Drug Pipeline
Dec 26 2023
PainReform Ltd Announces Exercise of Warrants, Garnering Approximately $1.3 Million in Gross ProceedsTEL AVIV, Israel, Dec. 26, 2023 (GLOBE NEWSW...

Dec 26 2023

Dec 26 2023


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com